戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 rmed cleft using a convex binding interface (paratope).
2 specific lipid binding sites of the antibody paratope.
3 ed the affinity limit achievable with a flat paratope.
4 dues suggested that this is not an optimized paratope.
5  only A2 contributes to the canonical Hib PS paratope.
6 ill" and VH "valley" shape of the grooved E8 paratope.
7 een this peptide and the monoclonal antibody paratope.
8 dated by structurally-similar changes in the paratope.
9 bclasses and IgA, consistent with an altered paratope.
10 icity with conformational versatility of the paratope.
11  sequence information on the location of the paratope.
12 nce-based information on the location of the paratope.
13 d in order to map the structural epitope and paratope.
14 al of 16 amino acid residues in the antibody paratope.
15  seven amino acids form part of the CAT-2200 paratope.
16 m pneumococcal capsular PS (PPS) 6B-specific paratopes.
17 tively charged amino acid residues in bNAbs' paratopes.
18 ties via their unusually long, convex-shaped paratopes.
19 es, mimicking the energetic core of antibody paratopes.
20 he minor portion of the predicted functional paratopes.
21 opes whose cognate mAbs have electropositive paratopes.
22 t a source for human antibodies with genuine paratopes.
23 nt in combination with other nonneutralizing paratopes.
24               It also occurs when a flexible paratope accommodates dissimilar Ags by adjusting struct
25 ope is fixed while variation in the antibody paratope allows increasing affinity.
26            The epitope as defined by the IgE paratope and a set of chimeric Bet v 1 fusion proteins a
27 nt of SCV therapeutics based on the antibody paratope and epitope, and a retrovaccinology approach fo
28 idating the role of C domains in shaping the paratope and influencing specificity is a critical area
29  remarkable feature revealed lies within the paratope and is a novel six-amino-acid alpha-helix that
30    Surprisingly, Tyr still dominates the YSX paratope and the additional amino acid types are primari
31 utralizing antibodies (bnAbs) with conserved paratopes and mutations, and in some cases, the same Ig-
32 in GloBodies, which retain the drug antibody paratopes and Nanoluciferase activity.
33 b segment reveals a well-defined polyanionic paratope, and the docking studies indicate that the poly
34 he antibody molecules reducing the hiding of paratopes, and (ii) maintained the activity of the captu
35                   We suggest that the convex paratope antibody libraries described here could be read
36                    Accurate knowledge of the paratope (antibody binding site) can speed up and reduce
37 ith orientation control for site-positioning paratopes (antigen binding site) of the antibody molecul
38         It is not clearly understood how the paratopes are able to recognize sequence-wise featureles
39 on average, complete structural epitopes and paratopes are equal in size to each other and similar in
40                                     Antibody paratopes are formed by hypervariable complementarity-de
41                               The functional paratopes are surrounded by favorable polar atomistic co
42 site thus comprises antibodies with distinct paratopes arrayed about two optimal geometric orientatio
43  epitope (i.e., the BC-loop) and a potential paratope at the N-terminus of the heavy chain.
44 to these three rotations positioning the Fab paratopes at a proper distance and orientation required
45 The peptide structures differed, and the two paratopes attained discrete conformations, leading to di
46 VRC01-class bnAb precursors with native-like paratopes but with intrinsic glycan adaptability.
47 nforcement of structural restrictions on the paratope by C(H)1 domains.
48 und surrogates of the intracellular antibody paratope (called antibody-derived [Abd] compounds) have
49                                     Although paratope chemistries differed, all 16 gp120-CD4bs antibo
50 ucture at 3.2 A resolution reveals a contact paratope composed almost entirely of tryptophan and seri
51 studies, the findings indicate that a hybrid paratope consisting of quinine and reconfigured antibody
52 , VH-V1a recognizes VEGF by using an unusual paratope consisting predominantly of CDR3 but with signi
53                          Mapping the epitope-paratope contact interfaces revealed that these function
54 l quality attribute for biotherapeutics with paratopes containing potential cis proline amide bonds.
55 omain (d7) to the membrane, and the antibody paratope contains electrostatic surfaces compatible with
56                  The key residues within the paratope contributing to binding were identified as Asp5
57 olding elements that physically separate the paratope-defining variable (V) region from the effector
58 nd use a combination of structural analysis, paratope dissection, and neutralization assessment to de
59 e switching generated a surprising degree of paratope diversity within the individuals analyzed.
60 f antibody responses is inherently linked to paratope diversity, as generated through V(D)J recombina
61  simultaneously via nonoverlapping epitopes-"paratope duality." One mode involved paratope gullying,
62                     Comparison of the SNV-42 paratope encoding variable genes with inferred germline
63                                        Thus, paratope engraftment may be used to expand the epitope r
64 density comparisons were used to analyze the paratope-epitope interface and demonstrated that the ant
65 stics of binding for these antibodies at the paratope-epitope interface.
66 y identical charge interactions occur at all paratope-epitope interfaces.
67 e polar atomistic contacts in the structural paratope-epitope interfaces; more that 80% these polar c
68  data provide a mechanistic insight into the paratope-epitope relationship between an alloantibody an
69 results highlight the importance not only of paratope/epitope complementarity but also the topologica
70 sin may be limiting the accessible space for paratope evolution.
71 tural analyses demonstrate that the improved paratope expands the FP binding groove to accommodate di
72 2, with a large reorientation of the binding paratope facilitating increases in contact surface and s
73 lonal within the individual, with one or two paratope families accounting for the majority of express
74  level, with the same two L-chain-determined paratope families recurring in all individuals.
75               Modeling demonstrates that the paratope forms a groove suitable for binding two beta-ri
76 othesize that the hydrophobic surface of the paratope functions as a "trap" for the viral sequences,
77 accommodate parts of the epitope in sizeable paratope gullies.
78 itopes-"paratope duality." One mode involved paratope gullying, whereas the other involved only CDRs,
79                               The functional paratope (hot spot) predictions on a set of 111 antibody
80 ng by grouping of lymphocyte interactions by paratope hotspots (GLIPH2) in a South African longitudin
81 H2 (grouping of lymphocyte interactions with paratope hotspots 2) algorithm.
82 LIPH (grouping of lymphocyte interactions by paratope hotspots) to cluster TCRs with a high probabili
83            Here, we rationally engraft a new paratope, i.e., the extended heavy-chain framework regio
84 edict mutational effects on antigen binding, paratope identification, and other key antibody properti
85 quence protected from proteolysis by the 2F5 paratope; (ii) downstream residues postulated to establi
86 y suggested direct involvement of a flexible paratope in the observed mimicry.
87 the size of a complete structural epitope or paratope, inclusive of CR and the minimum set of support
88 s could be used as specific non-covalent and paratope-independent handles in targeted drug delivery,
89  of EEEV by these mAbs including the epitope-paratope interaction surface, occupancy, and kinetic dif
90          The variables affecting the epitope-paratope interaction were further optimized using a chem
91       Structurally, we found similar epitope-paratope interactions across multiple gene rearrangement
92                                  The epitope-paratope interactions illustrate how these anti-pHis ant
93 nding site structure and the presence of key paratope interactions, which can occur even when their s
94 chitecture of the antigen as well as epitope-paratope interactions.
95 ntarity-determining regions that are driving paratope interactions; the variable light complementarit
96 velopment we identified sites on the epitope-paratope interface that are the focus of affinity optimi
97 ues and interactions that define the epitope-paratope interface.
98 ttached to humanized mAb C8, combining their paratopes into a single bsAb (C73).
99 e have developed a method to introduce novel paratopes into the human antibody repertoire by modifyin
100 verage of 3-4 such liability motifs in their paratopes, irrespective of the source dataset.
101 antigen complex revealed that the structural paratope is dominated by Tyr side-chains.
102 nesis experiments reveal that the functional paratope is dominated by Tyr, which represents 11 of the
103 contact between the B2.1 peptide and the b12 paratope is unlikely to mimic the discontinuous key bind
104 study has shown that the binding area, named paratope, is located at the surface of rituximab.
105 finity is engineered outside of the antibody paratope, it can complement affinity maturation strategi
106                        We chose a minimalist paratope limited to two loops found in a natural camelid
107                                          The paratope map of b12 may facilitate the design of molecul
108                                  Epitope and paratope mapping revealed few interactions with host-der
109 ; (iii) antigen selection increased antibody paratope net charge and solvent-accessible surface area;
110                     Our work also mapped the paratope of ADI-15946, thereby explaining reduced activi
111 njugating a cholesterol group outside of the paratope of an antibody.
112 ond CDR of the light chain forms part of the paratope of CAP256.25.
113 ubstitutions of selected residues to map the paratope of Fab 2F5.
114 ed approach was developed to map the epitope/paratope of PD-1/nivolumab.
115 ggesting that the peptides bind close to the paratope of the Ab.
116 an and tyrosine residues highly populate the paratope of the antibody but not the epitope of the anti
117                                 Instead, the paratope of the antibody undergoes a large conformationa
118  antibody and the second is specific for the paratope of the secondary detecting antibody.
119 e molecular binding interactions between the paratopes of antibodies and the epitopes of food allerge
120 ction-linked (PL) biopanning," probes the Ab paratopes of protected vaccinees versus those with vacci
121 variability of antigenic epitopes, where the paratope on the antibody binds specifically to a given e
122 plications such as the evolution of multiple paratopes or shelf-stable diagnostics and therapeutics.
123  employed thiophene-3-boronic acid (T3BA) as paratope orientation controller, (i) enabled site orient
124       Structural characterization of epitope-paratope pairs has contributed to the understanding of a
125 IV-1 elicits antibodies with human bnAb-like paratopes paradoxically unable to bind HIV-1.
126 s interdomain conformational flexibility and paratope plasticity during bnAb development.
127 ynamics simulations which revealed increased paratope plasticity in the scFv relative to the correspo
128 was systematically incorporated at different paratope positions.
129 ntibody binding-site composition at putative paratope positions.
130      We present Paragraph, a structure-based paratope prediction tool that outperforms current state-
131 he epitope, while graph models are better in paratope prediction, both achieving significant performa
132  we showcase state-of-the-art performance in paratope prediction.
133                                We describe a paratope raised against the human ErbB family member HER
134            The amino acid composition of the paratope reflects the library diversity, consisting most
135  structurally important positions within the paratope region and (b) tailored amino acid composition
136  Structurally important positions within the paratope region were identified through stability, struc
137 d "peptide matrix," inspired by the antibody paratope region, was fabricated on a surface plasmon res
138 ing sites in the GP trimer, and separate 1C3 paratope regions interact differently with identical res
139 finitive characterization of the epitope and paratope regions.
140 utagenesis to map the functional epitope and paratope residues that govern the antigen-antibody inter
141 sity to the light chain, by diversifying non-paratope residues that may influence CDR conformations,
142 iding models for the interacting epitope and paratope residues.
143 ing potential developability issues; predict paratope residues; and predict epitope patches on protei
144 bodies simultaneously, and identification of paratope sequence determinants for binding recognition f
145                  Using the isolated antibody paratope sequences we engineered a bispecific antibody c
146 gether appear to comprehensively explore the paratope space.
147 led molecular comparison of an anti-idiotype paratope specific for a human antibody with its analogou
148    1C3 is of particular interest because its paratope strongly binds with unique stoichiometry to the
149 ow protein topology, parental framework, and paratope structure and location all impact scaffold perf
150 traints on the variable (V) region to affect paratope structure in a V region identical IgG(1), IgG(2
151 omparable to those of mammalian TCR in basic paratope structure; additionally, nurse shark TCRdelta C
152                                          The paratope surface consists of residues located in four co
153 nfirmed that the mutated residue retains the paratope surface when compared with WT PG9.
154 yranosonic acid), displays a germ-line-coded paratope that differs significantly from previously char
155 ive bnAbs can be generated by human antibody paratopes that accommodate the conserved glycan differen
156                 Comparison of the respective paratopes that bind to carbohydrate and protein reveals
157 ey are significantly less common among those paratopes that bind to the immunodominant amino-terminal
158                          Possessing flexible paratopes that can recognize protein motifs inaccessible
159 the context of lipids, shaping MPER-specific paratopes through selective pressure.
160 odify the V region structure to alter the Ab paratope, thus providing an explanation for how isotype
161 ombined with alanine scanning of epitope and paratope to predict a model of FGF23-Burosumab interacti
162  four or five diverse, structurally distinct paratopes, to elucidate their impact on evolvability and
163                                 Six distinct paratope topologies observed for a single germline mAb p
164 y crystallography has shown that an antibody paratope typically binds 15-22 amino acids (aa) of an ep
165 tures and these patterns of naive repertoire paratope usage are highly conserved across subjects.
166 dict the bacterial recombinant expression of paratope variants of the protein scaffold Gp2.
167                           Interestingly, the paratope was mapped exclusively to the variable light ch
168 the parent 10E8 was the most soluble, with a paratope we showed crystallographically to be virtually
169 nies the removal of C domains from identical paratopes, we performed molecular dynamics simulations w
170  structures of large protein Ag epitopes and paratopes were analyzed to inform the process of eliciti
171                              The IgE and IgA paratopes were probed by nuclear magnetic resonance spec
172                     The predicted functional paratopes were reasonably validated by the hot spot resi
173 ecifically to a distinct conformation of the paratope, which was also different from that of the Ag-f
174 ue features, including small size and convex paratopes, which provide enhanced targeting of concave e
175 hich conformational convergence of different paratopes while binding to a common epitope in a similar
176 novel approach to the problem by probing the paratope with (15)N label peptide mimetics followed by N
177 nal residues located at the periphery of the paratope with a concomitant loss of the so-called "O-rin
178 t a limited repertoire of antibodies bearing paratopes with diverse structural contours enriched with
179                          Engineered antibody paratopes with limited sequence diversity permit assessm
180  methods were used to predict the functional paratopes with the 3D antibody variable domain structure
181 hain V region gene products to form specific paratopes, with no apparent tendency for conservation of
182 e the major part of the predicted functional paratopes, with short-chain hydrophilic residues forming

 
Page Top